FDA Logo links to FDA home page
U.S. Food and Drug Administration
  HHS Logo links to Department of Health and Human Services website
 MedWatch logoThe FDA Safety Information and Adverse Event Reporting Program

line line line line line

Stay Informed
Subscribe to receive safety alerts
Get e-mail updates By email | MedWatch RSS [XML] Feed By RSS

What's New

Innohep (tinzaparin sodium injection) - Clinical study stopped early because of interim finding of increase in all-cause mortality in patients who received Innohep.
(Posted 12/02/2008)

Erythropoiesis Stimulating Agents (ESAs) - Epoetin alfa (marketed as Procrit, Epogen), Darbepoetin alfa (marketed as Aranesp) - [UPDATE] FDA issued Q&As for recently approved Medication Guides.
(Posted 12/02/2008)

December 2008 Patient Safety News - Video news show for healthcare professionals, covering safety alerts, recalls, product approvals, and important tips on protecting patients.
(Posted 12/01/2008)

Starcaps Dietary Supplement Capsules - Recall due to undeclared drug, Bumetanide, resulting in drug interactions including risk of hypotension (low blood pressure), or fainting (syncope).
(Posted 11/26/2008)

Zhen De Shou Fat Loss Capsules - Recall due to undeclared sibutramine, an appetite suppressant known to substantially increase blood pressure and/or pulse rate in some patients.
(Posted 11/26/2008)

Phenytoin (marketed as Dilantin, Phenytek and generics) and Fosphenytoin Sodium (marketed as Cerebyx and generics) - Potential increased risk of serious skin reactions, including Stevens Johnson syndrome and toxic epidermal necrolysis, from phenytoin therapy in Asian patients positive for a particular human leukocyte antigen allele, HLA-B*1502.
(Posted 11/24/2008)

Animas Corporation Battery Caps Used with the OneTouch Ping System, Animas 2020 Insulin Pump, Animas IR1200 Insulin Pump, and Animas IR1250 Insulin Pump - Potential for device to stop administering insulin, resulting in hyperglycemia or hypoglycemia.
(Posted 11/20/2008)

Welcome to MedWatch, your Internet gateway for timely safety information on drugs and other medical products regulated by the U.S. Food and Drug Administration.


Safety Information

Safety Information


Medical Product

Medical Product Reporting

Educational Resources

 FDA MedWatch and Patient Safety

A self-learning tutorial covering the MedWatch program goals of broadcasting safety information and encouraging adverse event reporting. MedWatch tutorial screenshots

 Safety Information Resources for Health Professionals

Busy healthcare professionals need the best safety information at the right time to help manage their patients.

Windows: High | Medium
Real:         High | Medium

Video screenshot featuring FDA Director Dr. Janet Woodcock

horizonal rule